Zacks Investment Research upgraded shares of OMNICARE INC (OCR) from NEUTRAL to OUTPERFORM on August 21, 2012, with a target price of $39.40.
Omnicare, Inc., a Fortune five hundred company based in Covington, Kentucky, is a leading provider of pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities and other chronic care settings comprising beds in fourteen states, the District of Columbia and Canada. Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings. Omnicare's pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals. Omnicare offers clinical research services for the pharmaceutical and biotechnology industries in thirty countries worldwide.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on OMNICARE INC (OCR),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment